Integrating Quality Improvement into Clinical Governance Frameworks
This article explores the vital relationship between Quality Improvement (QI) and Clinical Governance within the NHS, demonstrating how they are two sides of the same coin when aiming for continuous, systematic improvement in patient care.
Clinical governance is a comprehensive framework designed to ensure that NHS organisations are continuously accountable for safeguarding high standards of care. It encompasses various domains, from patient safety and clinical audit to staff education and risk management. Quality Improvement (QI) methodologies provide the tools and structured approaches to actively drive the improvements identified or mandated by these governance processes.
Historically, QI and clinical governance have sometimes been viewed as separate functions, even leading to duplication of effort or missed opportunities for synergy. This resource aims to clarify their interconnectedness, offering practical guidance on how to embed QI within existing governance structures to create a more dynamic, responsive, and effective system for enhancing healthcare quality.
Why this topic matters
For NHS organisations, providing safe, effective, and person-centred care is paramount. Clinical governance sets the strategic direction and provides the oversight, while QI offers the practical 'how-to' for achieving those goals. A well-integrated system ensures that identified shortfalls or areas for development within governance domains are not just reported but are actively addressed through structured improvement initiatives. Without QI, governance risks becoming a passive reporting exercise. Without governance, QI risks becoming fragmented and unsustained.
Effective integration leads to:
- Systematic Improvement: Moving beyond isolated projects to systemic, lasting change.
- Enhanced Accountability: Clearer pathways from identified issues to implemented solutions.
- Efficient Resource Utilisation: Reducing duplication and ensuring efforts are aligned with organisational priorities.
- Improved Staff Engagement: Empowering staff with the tools to solve problems and contribute to better care.
- Better Patient Outcomes: Ultimately, driving tangible improvements in patient safety, effectiveness, and experience.
Practical explanation
Clinical governance is often described as having several core domains. While the exact categorisation may vary slightly between trusts, common domains include:
- Patient Safety: Identifying, reporting, and learning from adverse events and near misses.
- Clinical Audit: Systematic review of care against explicit criteria, followed by action if necessary.
- Effectiveness: Ensuring clinical care is evidence-based and achieves intended outcomes.
- Patient Experience/Engagement: Understanding and responding to patient feedback.
- Staffing & Staff Management: Including workforce planning, appraisal, education, and professional development.
- Risk Management: Proactive identification and mitigation of risks.
- Use of Information: Ensuring data quality, confidentiality, and appropriate use for improvement.
Quality Improvement provides methodologies (e.g., PDSA cycles, Lean, Six Sigma, Model for Improvement) to address challenges identified within these governance domains. For example, a clinical audit might identify a gap in compliance with a national guideline (Effectiveness domain). Instead of simply re-auditing, a QI project can be initiated to understand why the gap exists, test potential solutions, and embed sustainable change. Similarly, recurring patient safety incidents (Patient Safety domain) or negative patient feedback (Patient Experience) can trigger QI projects aimed at root cause analysis and implementing tested countermeasures.
The key is to view QI as the active engine within the governance framework, turning insights into action and sustaining positive change.
The relationship between QI and Clinical Governance
Think of it as a continuous loop:
- Identification: Clinical governance processes (e.g., incident reporting, audit results, complaints, risk registers, guideline updates) identify areas for improvement or non-compliance.
- Prioritisation & Scoping: Governance committees and clinical leads prioritise which issues need addressing, often based on risk, impact, and strategic alignment, and scope them as potential QI projects.
- Action through QI: QI teams or frontline staff, supported by QI expertise, use structured methodologies to analyse problems, develop hypotheses for change, test interventions, and implement solutions.
- Monitoring & Evaluation: Governance mechanisms oversee the progress of QI projects, ensuring they are well-managed, report on outcomes, and sustain improvements. Clinical audits or re-audits are often used to confirm the impact of QI interventions.
- Learning & Dissemination: Lessons learned from QI projects, both successful and unsuccessful, feed back into the wider governance system, informing policy, training, and future priorities.
Common pitfalls
- Isolation of Functions: QI teams operating in silos, disconnected from core governance committees or departments.
- Audit Without Action: Clinical audits identifying issues but lacking a structured process for implementing and monitoring changes.
- QI Without Oversight: Numerous QI projects running concurrently without clear strategic alignment, prioritisation, or governance oversight, leading to burnout or wasted effort.
- Lack of Mandate/Leadership Buy-in: QI initiatives failing to gain traction due to insufficient support from senior leadership or governance bodies.
- Poor Data Utilisation: Data collected for governance purposes (e.g., incident data, audit data) not being effectively used to inform and drive QI projects.
- Lack of Training and Capacity: Staff lacking the necessary QI skills to effectively address problems identified by governance processes.
Step-by-step approach to integration
1. Establish Clear Links and Reporting Lines
- Cross-representation: Ensure QI leads and clinical governance leads meet regularly and ideally have representation on relevant committees (e.g., QI lead on Clinical Governance Committee, Governance lead on QI steering group).
- Data Flow: Map how data from incident reporting, complaints, audits, and risk registers flow to QI teams or are used to identify potential QI projects.
- Decision-making: Define the process for how identified improvement areas are prioritised and allocated to QI, and how QI project proposals are reviewed and approved by governance.
2. Standardise the Improvement Cycle
- Adopt a trust-wide QI methodology: Encourage the use of a consistent approach (e.g., Model for Improvement with PDSA cycles) across all departments, providing a common language and framework.
- Integrate QI into existing pathways: For example, when an audit identifies a shortfall, the next step should explicitly involve scoping a QI project rather than just a re-audit.
3. Build Capacity and Capability
- Training: Provide QI training at various levels, from foundational awareness for all staff to advanced training for QI leads and faculty. This empowers staff to participate in and lead improvement.
- QI Coaching/Facilitation: Establish a network of QI coaches to support teams in applying methodologies effectively.
4. Leverage Digital Tools for Data and Project Management
- Integrated Dashboards: Develop dashboards that bring together governance data (e.g., incident rates, audit compliance) with QI project progress and outcomes.
- QI Project Software: Utilise platforms that allow teams to manage QI projects, track PDSA cycles, record data, and report progress, facilitating oversight.
5. Foster a Culture of Continuous Learning
- Share Learning: Create forums for sharing learning from QI projects and governance reviews, celebrating successes and learning from challenges.
- Feedback Loops: Ensure that feedback from governance committees informs QI efforts, and that QI outcomes inform governance reporting and strategic planning.
Example in clinical practice: Reducing Medication Errors on Wards
The Governance Trigger
- Incident reporting: Analysis of local incident reporting data over a quarter reveals a concerning trend of increasing medication administration errors, particularly related to intravenous fluid prescribing and administration, and 'wrong time' errors for routine medications.
- Clinical Audit: The annual clinical audit for medication safety identifies lower than expected compliance with ward-based medication reconciliation processes post-admission.
- Patient Complaints: Several patient complaints mention delays in receiving pain relief or antibiotics.
Prioritisation and Scoping (Governance Role)
- The Trust's Medication Safety Committee (a key governance body) reviews the incident data, audit findings, and complaints. They identify reducing medication errors on medical wards as a high-priority area due to patient safety implications and potential for harm.
- The committee mandates the lead pharmacist and general medical consultant to co-sponsor a QI project focused on this area.
QI Project (QI Team/Ward Staff Role)
- A multidisciplinary QI team (pharmacist, doctor, nurse, QI facilitator) is formed for Ward B.
- They use the Model for Improvement: What are we trying to accomplish? How will we know that a change is an improvement? What changes can we make that will result in improvement?
- Aim: Reduce medication administration errors on Ward B by 50% within six months.
- Measures: Primary outcome measure: rate of medication administration errors per 1000 doses (from incident reports). Process measures: compliance with medication reconciliation, staff completion rate of medication training.
- Changes: After initial data collection and root cause analysis (e.g., fishbone diagram, 5 Whys), identified changes might include:
- Standardising IV fluid charts, co-designed with staff.
- Implementing a 'red flag' system for high-risk medications at handover.
- Introducing a 'protected medication time' on the ward.
- Delivering targeted refresher training on medication administration protocols.
- PDSA cycles: Each change idea is tested on a small scale, refined, and then implemented more widely. For example, testing the 'protected medication time' during a single shift, refining the approach based on feedback, and then rolling it out across the ward.
Monitoring and Reporting (Governance Link)
- The QI team provides regular updates (e.g., monthly) to the Medication Safety Committee, showing run-charts of their primary and process measures.
- The committee reviews progress, offers support, and ensures the project remains aligned with trust-wide medication safety goals.
Sustaining and Spreading (Governance & QI)
- Once the 50% reduction in errors is sustained on Ward B for three consecutive months, the Medication Safety Committee supports the spread of successful interventions to other medical wards.
- These new practices are then embedded into local policy and considered for inclusion in mandatory training. Ongoing clinical audits continue to monitor compliance and outcomes.
This iterative process demonstrates how governance identifies concerns, QI addresses them systematically, and governance then ensures sustainability and spread, contributing to continuous organisational learning and improvement.
How Lazomis can help
Lazomis provides a suite of tools designed to support the seamless integration of QI into clinical governance:
- Project Management & Tracking: Use Lazomis to set up, track, and manage all your QI projects, linking them directly to identified governance priorities. Our dashboards can display progress against key performance indicators, making reporting to governance committees straightforward.
- Data Visualisation: Easily create run-charts and control charts to monitor the impact of your interventions for both QI and governance reporting. This helps in demonstrating measurable improvement and identifying when changes are truly statistically significant.
- Audit & Feedback Functionality: Integrate audit findings directly into the QI project pipeline helping you move from 'audit for audit's sake' to 'audit for improvement'.
- Centralised Knowledge Base: Store and share learning from successful QI projects and governance reviews, ensuring that valuable insights are not lost and can inform future initiatives.
- Collaboration Features: Facilitate multidisciplinary team collaboration on QI projects, connecting frontline staff with governance leads and QI facilitators within a single platform.
This resource supports, but does not replace, clinical judgement. Local policy, formulary and specialist advice should be followed.
Key takeaways
- Clinical governance sets the strategic direction for quality and safety, while Quality Improvement (QI) provides the methodologies for achieving these goals.
- Effective integration of QI into governance frameworks replaces passive reporting with active, structured improvement processes.
- Common pitfalls include isolated functions, audit without action, and lack of senior leadership buy-in for QI efforts.
- A structured approach involves establishing clear links, standardising improvement cycles, building staff capacity, and leveraging digital tools.
- Using integrated data and reporting helps governance committees oversee QI progress and ensures sustainability and spread of successful interventions.
- Lazomis tools can streamline QI project management, data visualisation, and reporting, supporting holistic governance and improvement cycles.
In summary
Understanding the dynamic relationship between Quality Improvement (QI) and Clinical Governance is crucial for all NHS teams aiming for continuous, systematic improvement in patient care. This resource provides a practical guide on integrating QI methodologies within your existing governance frameworks, ensuring that identified areas for improvement are actively addressed and sustained. Learn how to foster synergy, avoid common pitfalls, and leverage digital tools to enhance accountability and drive better patient outcomes.
Drive Smarter, More Integrated Improvement
Empower your teams to seamlessly link governance insights with powerful QI actions. Discover how Lazomis can transform your approach to clinical quality and safety.